Bill117th CongressFiled Mar 9, 2022Health
H.R. 7047
Lowering Costs by Improving Biosimilar Uptake Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Mar 9, 2022)
Lowering Costs by Improving Biosimilar Uptake Act
This bill allows for the omission of certain information relating to the strength of a product in a biosimilar application, as determined by the Food and Drug Administration.
What just happenedMar 10, 2022
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Schrader, Kurt [D-OR-5](D-OR)Sponsor
1committees4actions
- Introduced in HouseMar 9, 2022
- Mar 10, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 9, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 9, 2022IntroReferralIntro-H
Introduced in House
- Mar 9, 2022IntroReferral1000
Introduced in House